Analysts Set Ardent Health Partners, LLC (NYSE:ARDT) PT at $21.82

Ardent Health Partners, LLC (NYSE:ARDT) has received a consensus rating of “Buy” from the twelve brokerages that are presently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $22.00.

Several brokerages have recently issued reports on ARDT. Stephens reiterated an “overweight” rating and issued a $24.00 target price on shares of Ardent Health Partners in a research note on Thursday, September 19th. KeyCorp initiated coverage on Ardent Health Partners in a report on Friday, October 11th. They issued an “overweight” rating and a $24.00 target price for the company. Royal Bank of Canada reaffirmed an “outperform” rating and set a $23.00 price target on shares of Ardent Health Partners in a report on Thursday, November 14th. Bank of America downgraded shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and dropped their price target for the company from $22.00 to $19.00 in a report on Wednesday, November 6th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a research report on Tuesday.

Institutional Investors Weigh In On Ardent Health Partners

Several large investors have recently bought and sold shares of ARDT. BNP Paribas Financial Markets purchased a new position in shares of Ardent Health Partners in the 3rd quarter worth $42,000. Financial Management Professionals Inc. purchased a new stake in Ardent Health Partners during the 3rd quarter valued at $50,000. MetLife Investment Management LLC bought a new stake in Ardent Health Partners in the third quarter worth $135,000. Quadrature Capital Ltd purchased a new position in Ardent Health Partners during the third quarter worth $229,000. Finally, Barclays PLC bought a new position in Ardent Health Partners during the third quarter valued at $385,000.

Ardent Health Partners Stock Down 0.7 %

ARDT stock opened at $16.05 on Friday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The company’s 50 day moving average is $17.30. Ardent Health Partners has a twelve month low of $14.57 and a twelve month high of $20.72.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.